Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 305 entries
View as:

the Dissection of Lymph Node Posterior to Right Recurrent Laryngeal Nerve for Papillary Thyroid Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03813706 Org: User:
Start: 01/31/20 End: 12/31/40 Due: 12/31/41

A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of Severe Hepatitis (Liver Failure) Complicated With Infection

Phase: N/A Priority: Normal
NCT ID: NCT06272071 Org: User:
Start: 03/31/24 End: 11/30/26 Due: 11/30/27

NKG2D CAR-NK & r/rAML

Phase: N/A Priority: Normal
NCT ID: NCT05734898 Org: User:
Start: 03/31/23 End: 09/30/24 Due: 09/30/25

Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT05846347 Org: User:
Start: 05/15/23 End: 04/19/25 Due: 04/19/26

Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02034968 Org: User:
Start: 02/28/14 End: 01/31/17 Due: 01/31/18

Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06367673 Org: User:
Start: 04/30/24 End: 08/31/26 Due: 08/31/27

APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04657861 Org: User:
Start: 05/03/22 End: 08/20/27 Due: 08/20/28

A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China

Phase: N/A Priority: Normal
NCT ID: NCT05886114 Org: User:
Start: 05/28/23 End: 04/28/27 Due: 04/28/28

Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02580253 Org: User:
Start: 11/01/17 End: 12/31/18 Due: 12/31/19

Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT01207297 Org: User:
Start: 03/31/03 End: 06/30/10 Due: 06/30/11

Diagnosis and Follow-up of Patients With Subclinical Hypothyroidism

Phase: N/A Priority: Normal
NCT ID: NCT00497575 Org: User:
Start: 10/31/99 End: 09/30/06 Due: 09/30/07

The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT03708887 Org: User:
Start: 10/10/20 End: 02/28/22 Due: 02/28/23

GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients

Phase: N/A Priority: Normal
NCT ID: NCT03869294 Org: User:
Start: 01/01/14 End: 12/31/17 Due: 12/31/18

Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT07021534 Org: User:
Start: 06/10/25 End: 12/31/26 Due: 12/31/27

Study Comparing Circular Stapler-assisted Colostomy vs Hand-stitching Colostomy of Colorectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02652702 Org: User:
Start: 12/31/16 End: 01/31/20 Due: 01/31/21

A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05155189 Org: User:
Start: 12/09/21 End: 05/31/41 Due: 05/31/42

Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04413734 Org: User:
Start: 04/22/20 End: 04/22/24 Due: 04/22/25

Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06793241 Org: User:
Start: 01/31/25 End: 01/31/28 Due: 01/31/29

Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06461624 Org: User:
Start: 07/01/24 End: 10/31/27 Due: 10/31/28

Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT05433935 Org: User:
Start: 07/01/22 End: 12/31/33 Due: 12/31/34

Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06168552 Org: User:
Start: 12/15/23 End: 12/15/24 Due: 12/15/25

Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06633341 Org: User:
Start: 10/20/24 End: 10/20/27 Due: 10/20/28

Multi-center Clinical Application of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03985644 Org: User:
Start: 07/31/19 End: 12/31/20 Due: 12/31/21

Study on the Effect of Dietary Supplements on Height Improvement in Children

Phase: N/A Priority: Normal
NCT ID: NCT05747560 Org: User:
Start: 06/20/23 End: 12/30/23 Due: 12/30/24

Impact of Skeletal Muscle Quality and Loss on the Outcome of Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06188273 Org: User:
Start: 01/01/24 End: 01/01/29 Due: 01/01/30